FIELD: chemistry.
SUBSTANCE: invention relates to formula (I) compounds and to their use in treating diseases related to lipid storage disorders, such as atherosclerosis and diabetes. In R1 represents hydrogen, alkyl, halogen, formyl, hydroxyalkyl or trifluoromethyl, R2 represents hydrogen, alkyl or halogen, R3 represents hydrogen or alkyl, R4 represents hydrogen, alkyl, hydroxy or alkoxy, R5 and R6 are chosen from hydrogen, alkyl, phenylalkyl, hydroxyalkyl, alkoxycarbonyl and phenyl, A represents aryl or heterocyclyl, m equals 0-3, n equals 0-1, p equals 0-3, sum of m, n and p equals 1-4, the bond between carbon atoms Ca and Cb is a single or double carbon-carbon bond.
EFFECT: obtaining new biologically active compounds.
27 cl, 147 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL HEXAFLUOROISOPROPANOL DERIVATIVES | 2005 |
|
RU2389718C2 |
HEXAFLUOROISOPROPANOL-SUBSTITUTED ETHER DERIVATIVES | 2005 |
|
RU2383524C2 |
NOVEL CYCLOHEXANE DERIVATIVES | 2005 |
|
RU2382029C2 |
HETEROCYCLIC COMPOUNDS AND APPLICATION METHODS | 2002 |
|
RU2345983C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2278863C2 |
N-SUBSTITUTED 1H-INDOLE-5-PROPIONIC ACIDS, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS AND THEIR USING (VARIANTS) | 2003 |
|
RU2296759C2 |
DERIVATIVES OF AMINOPYRAZOL | 2008 |
|
RU2489426C2 |
2,3-DIHYDRO-6-NITROAMIDAZO [2,1-b] OXAZOLE DERIVATIVES | 2003 |
|
RU2326121C2 |
3-AMINO-1-ARYLPROPYLINDOLES APPLIED AS INHIBITOR MONOAMINE REUPTAKE | 2005 |
|
RU2382031C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS | 2005 |
|
RU2406725C2 |
Authors
Dates
2009-09-27—Published
2005-04-26—Filed